The Need for Adaptive Trial Design in Oncology Studies November 18, 2021 International Clinical Trials Read More › 24 Nov, 2021
4G Clinical Debuts its All-New Trial Trends Podcast WELLESLEY, Mass. - October 27, 2021 – 4G Clinical is proud to announce the launch of ... Read More › 27 Oct, 2021
4G Clinical Nominated for Powerhouse Company of the Year at New England Venture Capital Association’s 2021 NEVY Awards WELLESLEY, Mass. – October 14, 2021 – Today, 4G Clinical announced that it has been s... Read More › 14 Oct, 2021
A Metastatic Breast Cancer (MBC) Patient’s Journey to ‘No Active Disease’ The moment that Hannah Earle was diagnosed with breast cancer, she was holding a fuss... Read More › 15 Sep, 2021
Why the Pandemic is a Crucible for Clinical Trial Innovation September 13, 2021 Drug Discovery Trends Read More › 13 Sep, 2021
A Rare Disease Patient Sheds Light on Journey for Treatment 4G Clinical’s Senior Director of Marketing, Amy Ripston, had the opportunity to inter... Read More › 1 Sep, 2021
4G Clinical Ranks No. 111 on the 2021 Inc. 5000, With Three-Year Revenue Growth of 3,699 Percent Inc. Magazine Reveals Annual List of America’s Fastest-Growing Private Companies—the ... Read More › 17 Aug, 2021
Patient Choice Will Drive Adoption of Decentralized Clinical Trials August 6, 2021 The Association of Clinical Research Professionals Read More › 6 Aug, 2021
4G Clinical Raises $230M to Expand its RTSM Global Reach, Product Capabilities June 29, 2021 Fierce Biotech Read More › 29 Jun, 2021
Is Direct-to-Patient (DtP) the Tip of the Virtual Trial Iceberg? Is Direct-to-Patient (DtP) the Tip of the Virtual Trial Iceberg? Read More › 30 Sep, 2020
Direct-to-Patient (DtP) in Review – What Would We Have Done Differently if We Knew COVID-19 was Coming? Read More › 10 Sep, 2020
.png)
.png)
.png)
.png)
